Search By Initial

Cas Index 1

• 121660-11-5 | (2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)methanol (Catalog# : 81305)Related API & intermediates:Cas#147526-32-7 Pitavastatin CalciumCas# 24922-02-9 E
• 1257704-57-6 | CEP-33779 (Catalog# : 73105)CEP33779 is a selective JAK2 inhibitor with IC50 of 1.8 nM. CEP33779(< 3 M) inhibi
• 1450655-76-1 | CPI-169(racemate) (Catalog# : 72804)CPI-169 racemate is the racemate form of CPI-169, which is a novel and potent EZH2 in
• 1895895-38-1 | CHZ868(CHZ-868) (Catalog# : 72001)CHZ868,a type II JAK inhibitor, would demonstrate activity in JAK inhibitor persisten
• 1143532-39-1 | Capivasertib ( AZD5363 ) (Catalog# : 71805)Capivasertib is a novel pyrrolopyrimidine derivative, and an orally available inhibit
• 1374640-70-6 | CO-1686(Rociletinib) (Catalog# : 60701)CO-1686(Rociletinib) is an irreversible inhibitor of epidermal growth factor receptor
• 135463-81-9 | Coluracetam (Catalog# : 52782)Coluracetam(MKC-231) is a new choline uptake enhancer.
• 1369761-01-2 | Cerdulatinib (PRT062070, PRT2070) (Catalog# : 52780)Cerdulatinib (PRT-062070) is an oral active, multi-targeted tyrosine kinase inhibitor
• 1140909-48-3 | Cabozantinib S-malate (Catalog# : 52778)Cabozantinib S-malate (XL184, BMS-907351) is a potent VEGFR2 inhibitor with IC50 of 0
• 1138549-36-6 | CX-5461 (Catalog# : 52748)CX-5461 is an inhibitor of rRNA synthesis, selectively inhibits Pol I-driven transcri
• 1159824-67-5 | CZC24832 (Catalog# : 52735)CZC24832 is a selective inhibitor of PI 3-kinase (IC50 = 1.0 M in a PI 3-K-dependent
• 1045792-66-2 | CAY10603 (Catalog# : 52705)CAY10603 is a potent and selective inhibitor of HDAC6 with IC50 of 2 pM, as compared
• 1256963-02-6 | CDK4-IN-1 (Catalog# : 52610)CDK4 inhibitor is a novel and specific CDK4/Cyclin D1 inhibitor with an IC50 of 10 nM
• 1191911-27-9 | CZC-54252 (Catalog# : 52566)CZC-54252 is a potent inhibitor of LRRK2 with IC50s of 1.28 nM and 1.85 nM for wild-t
• 1056634-68-4 | CYT387 (Catalog# : 52534)CYT387(momelotinib) is an ATP-competitive inhibitor of JAK1/JAK2 with IC50 of 11 nM/1
• 112522-64-2 | CI-994 (Catalog# : 52517)CI-994 (Tacedinaline) is an anti-cancer drug which inhibits HDAC1 with IC50 of 0.57 M
• 1439934-41-4 | CTX-0294885 (Catalog# : 52213)CTX-0294885 is a a novel bisanilino pyrimidine; exhibits inhibitory activity against
• 1202916-90-2 | CX-6258 (Catalog# : 52234)CX-6258 is a potent, orally efficacious Pim 1/2/3 kinase(IC50=5 nM/25 nM/16 nM) inhib
• 1256589-74-8 | CH5424802 Hydrochloride (Catalog# : 51606)CH5424802 Hcl (AF 802 Hcl; Alectinib Hcl) is a potent ALK inhibitor with IC50 of 1.9
• 1009820-21-6 | CX-4945(Silmitasertib) (Catalog# : 52024)Silmitasertib (CX-4945) is a potent and selective orally bioavailable small molecule
• 1004316-88-4 | Cobicistat(GS-9350) (Catalog# : 51906)Cobicistat is a potent inhibitor of cytochrome P450 3A enzymes, including the importa
• 1784086-71-0 | 5,7-Difluoro-3-methylbenzofuran-2-carbaldehyde (Catalog# : 25129)
• 146255-66-5 | DHPG (Catalog# : 25056)DHPG, also known as (RS)-3,5-DHPG, is a selective agonist for group I metabotropic gl
• 1516679-30-3 | 1,3-dimethyl-1H-indazole-6-carbonitrile (Catalog# : 25037)
• 1413431-07-8 | Deutivacaftor (Catalog# : 24096)Deutivacaftor, also known as CTP-656 and VX561, is a cystic fibrosis transmembrane co
• 1399177-37-7 | Denifanstat (Catalog# : 20596)TVB-2640 is an orally bioavailable fatty acid synthase (FASN) inhibitor, with potenti
• 1932352-50-5 | 1,1-Dimethylethyl (1S,5S)-1-formyl-3-azabicyclo[3.1.0]hexane-3-carboxylate (Catalog# : 20545)
• 1932410-93-9 | 1,1-Dimethylethyl (1R,5S)-1-ethynyl-3-azabicyclo[3.1.0]hexane-3-carboxylate (Catalog# : 20544)
• 1932534-25-2 | 1,1-Dimethylethyl (1S,5S)-1-(hydroxymethyl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (Catalog# : 20543)
• 1059070-10-8 | DSR-6434 (Catalog# : 20497)DSR-6434 is a potent TLR7 agonist (EC50 = 7.2 nM). DSR-6434 activates several immune